Submit a comment

Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma

Rimas V. Lukas, Ruochen Du, Harrshavasan Congivaram, Kathleen McCortney, Karan Dixit, Craig Horbinski, Margaret Schwartz, Raymond Lezon, Lauren Singer, Ditte Primdahl, Jigisha Thakkar, Amy B. Heimberger, Roger Stupp, Priya Kumthekar

Rimas V. Lukas, Ruochen Du, Harrshavasan Congivaram, Kathleen McCortney, Karan Dixit, Craig Horbinski, Margaret Schwartz, Raymond Lezon, Lauren Singer, Ditte Primdahl, Jigisha Thakkar, Amy B. Heimberger, Roger Stupp, Priya Kumthekar

View: Text | PDF

Research Letter Neuroscience Oncology

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

• Comments appear on the Journal’s website and are linked from the original article’s web page.
• Authors are notified by email if their comments are posted.
• The Journal reserves the right to edit comments for length and clarity.
• No appeals will be considered.
• Comments are not indexed in PubMed.

Specific requirements

• Maximum length, 400 words
• Entered as plain text or HTML
• Author’s name and email address, to be posted with the comment
• Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
• Comments may not include figures